Figures
Evidence on drug treatments for COVID-19
Since the emergence of SARS-CoV-2 infections at the end of 2019, COVID-19 has imposed a severe burden of illness and mortality on the world’s population. Amid uncertain national and international efforts to contain the spread of infection through non-pharmacological means such as restrictions on lifestyles and travel, intensive clinical research has been carried out to develop treatments for patients with COVID-19, alongside urgent programs to create vaccines able to prevent further infections. In a research article in PLOS Medicine, Min Seo Kim and co-workers report a systematic review and network meta-analysis of evidence from randomized trials and observational studies on pharmacological treatments for COVID-19.
Image Credit: NIAID-RML, Flickr
Citation: (2021) PLoS Medicine Issue Image | Vol. 17(12) February 2021. PLoS Med 17(12): ev17.i12. https://doi.org/10.1371/image.pmed.v17.i12
Published: February 10, 2021
Copyright: © 2021 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Since the emergence of SARS-CoV-2 infections at the end of 2019, COVID-19 has imposed a severe burden of illness and mortality on the world’s population. Amid uncertain national and international efforts to contain the spread of infection through non-pharmacological means such as restrictions on lifestyles and travel, intensive clinical research has been carried out to develop treatments for patients with COVID-19, alongside urgent programs to create vaccines able to prevent further infections. In a research article in PLOS Medicine, Min Seo Kim and co-workers report a systematic review and network meta-analysis of evidence from randomized trials and observational studies on pharmacological treatments for COVID-19.
Image Credit: NIAID-RML, Flickr